BSE Live
Dec 04, 16:01Prev. Close
151.70
Open Price
151.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 04, 15:59Prev. Close
151.55
Open Price
152.00
Bid Price (Qty.)
152.10 (42560)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Sun Pharma Advanced Research Company (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | |
| 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -342.78 | -386.83 | -222.58 | |
| Net CashFlow From Operating Activities | -360.29 | -429.19 | -69.12 | |
| Net Cash Used In Investing Activities | 157.66 | 391.53 | -548.28 | |
| Net Cash Used From Financing Activities | 199.26 | 42.41 | 616.76 | |
| Foreign Exchange Gains / Losses | 0.01 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -3.37 | 4.75 | -0.64 | |
| Cash And Cash Equivalents Begin of Year | 5.33 | 0.58 | 1.22 | |
| Cash And Cash Equivalents End Of Year | 1.96 | 5.33 | 0.58 |
17.11.2025
Sun Pharma Adv Consolidated September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.11.2025
Sun Pharma Adv Standalone September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
17.11.2025
Sun Pharma Adv Consolidated September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.11.2025
Sun Pharma Adv Standalone September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y